Viewing Study NCT04765059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:50 PM
Ignite Modification Date: 2026-01-31 @ 10:43 PM
Study NCT ID: NCT04765059
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-01
First Post: 2021-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osimertinib View
None Platinum View
None Pemetrexed View
None Epidermal growth factor receptor mutation positive (EGFRm) View
None Extracranial progression View